Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease

Journal of Clinical Neuroscience

Volumn 21, Issue 8, 2014, Pages 1373-1376

  Sayin, Sevgi ^a   Çakmur, Raif ^b   Yener, Görsev G ^b   Yaka, Erdem ^b   Uǧurel, Burcu ^c   Uzunel, Fatma ^b  

^a Sakarya State Hospital   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Dyskinesia; Motor performance; Parkinson's disease; Repetitive transcranial magnetic stimulation; Supplementary motor area

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DYSKINESIA; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LEVODOPA INDUCED DYSKINESIA; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR PERFORMANCE; PARKINSON DISEASE; PLACEBO EFFECT; PREMOTOR CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTARY MOTOR AREA; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; DYSKINESIA, DRUG-INDUCED; MOTOR ACTIVITY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; VIDEORECORDING;

AGED; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VIDEO RECORDING;

EID: 84904250670     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.11.025     Document Type: Article

References (28)

1. R. Marconi, D. Lefebvre-Caparros, and A.M. Bonnet et al. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology Mov Disord 9 1994 2 12
2. S. Fahn The spectrum of levodopa-induced dyskinesias Ann Neurol 47 2000 S2 S9
3. O. Rascol, D.J. Brooks, and A.D. Korczyn et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group N Engl J Med 342 2000 1484 1491
4. G. Fabbrini, J.M. Brotchie, and F. Grandas et al. Levodopa-induced dyskinesias Mov Disord 22 2007 1379 1389
5. J.A. Obeso, M.C. Rodriguez-Oroz, and M. Rodriguez et al. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model Ann Neurol 47 2000 S22 S32
6. E. Bezard, J.M. Brotchie, and C.E. Gross Pathophysiology of levodopa-induced dyskinesia: potential for new therapies Nat Rev Neurosci 8 2001 577 588
7. K. Widnell Pathophysiology of motor fluctuations in Parkinson's disease Mov Disord 20 2005 17 22
8. L. Brusa, V. Versace, and G. Koch et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease Clin Neurophysiol 117 2006 1917 1921
9. O. Rascol, U. Sabatini, and C. Brefel et al. Cortical motor overactivation in parkinsonian patients with l-DOPA-induced peak-dose dyskinesia Brain 121 1998 527 533
10. D.J. Brooks, P. Piccini, and N. Turjanski et al. Neuroimaging of dyskinesia Ann Neurol 47 2000 S154 S158
11. G. Koch, L. Brusa, and C. Caltagirone et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease Neurology 65 2005 623 625
12. A. Wagle-Shukla, M.J. Angel, and C. Zadikoff et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias Neurology 68 2007 704 705
13. S.R. Filipović, J.C. Rothwell, and B.P. van de Warrenburg et al. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease Mov Disord 24 2009 246 253
14. A.J. Hughes, S.E. Daniel, and L. Kilford et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
15. S. Fahn, R.L. Elton, and UPDRS Development Committee Unified Parkinson's disease rating scale S. Fahn, C.D. Marsden, D. Calne, M. Golstein, Recent developments in Parkinson's disease 2 1986 MacMillan Healthcare Information Florham Park, NY 153 163 [293-304]
16. P.R. May, M.A. Lee, and R.C. Bacon Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches Clin Neuropharmacol 6 1983 35 51
17. D. Centonze, G. Bernardi, and G. Koch Mechanisms of disease: basic-research-driven investigations in humans - the case of hyperkinetic disorders Nat Clin Pract Neurol 3 2007 572 580
18. G. Koch RTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets Restor Neurol Neurosci 28 2010 561 568
19. H. Yu, D. Sternad, and D.M. Corcos et al. Role of hyperactive cerebellum and motor cortex in Parkinson's disease Neuroimage 35 2007 222 233
20. M.M. Lewis, C.G. Slagle, and A.B. Smith et al. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo- cortical motor circuitries Neuroscience 147 2007 224 235
21. G. Koch, L. Brusa, and F. Carrillo et al. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease Neurology 73 2009 113 119
22. T. Bäumer, R. Lange, and J. Liepert et al. Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans Neuroimage 20 2003 550 560
23. R.E. Hoffman, and I. Cavus Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders Am J Psychiatry 159 2002 1093 1102
24. C.G. Goetz, S. Leurgans, and R. Raman et al. Objective changes in motor function during placebo treatment in PD Neurology 54 2000 710 714
25. R. de la Fuente-Fernández, and A.J. Stoessl The placebo effect in Parkinson's disease Trends Neurosci 25 2002 302 306
26. R. de la Fuente-Fernández, M. Schulzer, and A.J. Stoessl Placebo mechanisms and reward circuitry: clues from Parkinson's disease Biol Psychiatry 56 2004 67 71
27. R. de la Fuente-Fernández, S. Lidstone, and A.J. Stoessl Placebo effect and dopamine release J Neural Transm Suppl 70 2006 415 418
28. S.C. Lidstone, M. Schulzer, and K. Dinelle et al. Effects of expectation on placebo-induced dopamine release in Parkinson disease Arch Gen Psychiatry 67 2010 857 865